Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Tremelimumab AstraZeneca | tremelimumab | 2023-02-20 | AstraZeneca AB |
Imjudo | tremelimumab | 2023-02-20 | AstraZeneca AB |
EMA:Drugs approved by European Medicines Agency through centralized Procedure.
HMA:Drugs approved by EU members through Mutual Recognition Procedure.
For more information check in official website of members:
Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Tremelimumab AstraZeneca | tremelimumab | 2023-02-20 | AstraZeneca AB |
Imjudo | tremelimumab | 2023-02-20 | AstraZeneca AB |